2017
DOI: 10.18413/2500-235x-2017-3-1-18-31
|View full text |Cite
|
Sign up to set email alerts
|

The Development of Hypertensive Neuroretinopathy Model on Wistar Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 2 publications
0
6
0
Order By: Relevance
“…In an experimental study of retinal ischemia-reperfusion, a simulated mechanical pressure of up to 110 mm Hg was reproduced in the anterior chamber of the eye for 30 minutes (Peresypkina et al 2017), as a result of which we found pronounced microcirculatory disorders and destructive neuronal changes with the highest vulnerability of the retinal ganglion layer. In addition, there were obvious changes in paravascular structures near the cribriform plate and inside the optic nerve (unpublished data).…”
Section: Clinical Evidence and Applied Aspects Of The Glymphatic Systmentioning
confidence: 82%
“…In an experimental study of retinal ischemia-reperfusion, a simulated mechanical pressure of up to 110 mm Hg was reproduced in the anterior chamber of the eye for 30 minutes (Peresypkina et al 2017), as a result of which we found pronounced microcirculatory disorders and destructive neuronal changes with the highest vulnerability of the retinal ganglion layer. In addition, there were obvious changes in paravascular structures near the cribriform plate and inside the optic nerve (unpublished data).…”
Section: Clinical Evidence and Applied Aspects Of The Glymphatic Systmentioning
confidence: 82%
“…In the fourth group of animals, recombinant erythropoietin was injected into the withers area in a dose of 50 IU/kg of rat mass (Peresypkina et al 2014) once every 3 days, 30 minutes before administering L-NAME.…”
Section: Methodsmentioning
confidence: 99%
“…Simulation of hypertensive neuroretinopathy was performed by daily i/p injection of a non-selective inhibitor of ΝΟ-synthases N-nitro-L-arginine methyl ester (L-NA-ME) (Sigma, Germany) in a dose of 12.5 mg/kg in form of an aqueous solution for 28 days and a single increase in intraocular pressure (IOP) to reach 110 mmHg by applying mechanical pressure to the anterior chamber of the eye for 5 min on the 26 th day of the experiment (Peresypkina et al 2017).…”
Section: Methodsmentioning
confidence: 99%